TCM
Texan Capital Management Portfolio holdings
AUM
$154M
Turnover
12.61%
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
+2.76%
1 Year Est. Return
+10.82%
3 Year Est. Return
+19.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$214M
AUM Growth
+$1.85M
(+0.87%)
Cap. Flow
-$2.42M
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
25.62%
Holding
135
New
7
Increased
33
Reduced
52
Closed
5
Avg Time Held
2.3
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.18M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$1.01M |
| 3 |
IBM
IBM
|
+$621K |
| 4 |
U.S. SILICA HOLDINGS, INC.
SLCA
|
+$582K |
| 5 |
AbbVie
ABBV
|
+$499K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.98M |
| 2 |
Goldman Sachs
GS
|
+$1.86M |
| 3 |
Cullen/Frost Bankers
CFR
|
+$1.39M |
| 4 |
Under Armour Class C
UA
|
+$1.15M |
| 5 |
Walmart Inc
WMT
|
+$517K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 34.44% |
| 2 | Healthcare | 11.52% |
| 3 | Financials | 8.75% |
| 4 | Communication Services | 8.34% |
| 5 | Technology | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Innovex International
INVX
$1.95B
| $9.01M | 4.21% |
150,025
-175
| -0.1% | -$9.74K |
2013 Q2
14 quarters
|
|
2
Enterprise Products Partners
EPD
$77.3B
| $6.77M | 3.16% |
250,469
-1,404
| -0.6% | -$36.6K |
2013 Q2
14 quarters
|
|
|
MMP
3
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $6.49M | 3.03% |
85,869
-1,400
| -2% | -$98K |
2013 Q2
14 quarters
|
|
4
Main Street Capital
MAIN
$5B
| $5.42M | 2.53% |
147,402
-5,838
| -4% | -$206K |
2013 Q2
14 quarters
|
|
5
Altria Group
MO
$122B
| $4.96M | 2.32% |
73,338
+3,642
| +5% | +$235K |
2014 Q3
9 quarters
|
|
6
Verizon
VZ
$185B
| $4.92M | 2.3% |
92,123
+3,546
| +4% | +$177K |
2015 Q1
7 quarters
|
|
7
ExxonMobil
XOM
$728B
| $4.67M | 2.18% |
51,791
-850
| -2% | -$74.3K |
2013 Q2
14 quarters
|
|
8
DELISTED
Walgreens Boots Alliance
WBA
| $4.48M | 2.09% |
54,145
-242
| -0.4% | -$20K |
2013 Q3
13 quarters
|
|
9
Merck
MRK
$364B
| $4.43M | 2.07% |
78,804
+5,803
| +8% | +$340K |
2013 Q2
14 quarters
|
|
10
Amazon
AMZN
$2.74T
| $3.66M | 1.71% |
97,640
-2,440
| -2% | -$95.6K |
2014 Q1
11 quarters
|
|
|
SEP
11
DELISTED
Spectra Engy Parters Lp
SEP
| $3.62M | 1.69% |
78,924
| – | – |
2015 Q2
6 quarters
|
|
12
EOG Resources
EOG
$80.9B
| $3.6M | 1.68% |
35,640
-798
| -2% | -$77.7K |
2013 Q2
14 quarters
|
|
13
DELISTED
Pioneer Natural Resource Co.
PXD
| $3.4M | 1.59% |
18,861
-186
| -1% | -$34.1K |
2016 Q3
1 quarter
|
|
14
GE Aerospace
GE
$319B
| $3.3M | 1.54% |
21,763
-1,335
| -6% | -$194K |
2013 Q2
14 quarters
|
|
15
Alphabet (Google) Class A
GOOGL
$4.25T
| $3.27M | 1.53% |
82,660
-1,940
| -2% | -$77.6K |
2015 Q4
4 quarters
|
|
16
Plains All American Pipeline
PAA
$17.6B
| $3.27M | 1.53% |
101,428
-2,000
| -2% | -$63.2K |
2013 Q2
14 quarters
|
|
17
Johnson & Johnson
JNJ
$612B
| $3.27M | 1.53% |
28,400
+1,810
| +7% | +$209K |
2013 Q2
14 quarters
|
|
18
DELISTED
Anadarko Petroleum
APC
| $3.15M | 1.47% |
45,232
+195
| +0.4% | +$12.7K |
2013 Q2
14 quarters
|
|
19
Intel
INTC
$519B
| $3.04M | 1.42% |
83,901
-4,909
| -6% | -$176K |
2013 Q2
14 quarters
|
|
20
Microsoft
MSFT
$3.96T
| $3.02M | 1.41% |
48,623
-979
| -2% | -$58.9K |
2013 Q2
14 quarters
|
|
|
VVC
21
DELISTED
Vectren Corporation
VVC
| $2.99M | 1.4% |
57,298
| – | – |
2015 Q2
6 quarters
|
|
|
22
Bristol-Myers Squibb
BMY
$121B
| $2.98M | 1.39% |
50,982
-36,218
| -42% | -$1.98M |
2013 Q2
14 quarters
|
|
23
Apple
AAPL
$5.01T
| $2.93M | 1.37% |
101,112
-2,644
| -3% | -$75K |
2013 Q2
14 quarters
|
|
24
JPMorgan Chase
JPM
$890B
| $2.81M | 1.31% |
32,569
-1,358
| -4% | -$104K |
2016 Q2
2 quarters
|
|
|
ULQ
25
DELISTED
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
| $2.78M | 1.3% |
55,460
| – | – |
2016 Q3
1 quarter
|
|
Similar funds
WI
IA
W
4IG
AFA
BGC
YP
CCM
Texan Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Texan Capital Management held 135 positions worth $214M, up 0.87% from $212M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Texan Capital Management's Q4 2016 filing shows 7 new, 33 increased, 52 reduced and 5 closed positions. Its largest new stake was Abiomed Inc: 8,719 shares worth $982K. The largest sale was Bristol-Myers Squibb, an estimated $1.98M.
By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- Texan Capital Management's largest Q4 2016 buy was Abiomed Inc: 8,719 shares worth $982K.
- Texan Capital Management added most to Procter & Gamble in Q4 2016, an estimated $1.18M increase.
- Texan Capital Management's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $1.98M.
- Texan Capital Management fully exited Goldman Sachs in Q4 2016, selling an estimated $1.86M.
- Texan Capital Management's ten largest holdings make up 26% of its $214M portfolio in Q4 2016.
- Texan Capital Management opened 7 new positions and closed 5 in Q4 2016.
- Texan Capital Management's portfolio value rose 0.87% quarter-over-quarter to $214M.
Based on Texan Capital Management's 13F filing for Q4 2016, filed 3 Feb 2017.